Dyadic Applied BioSolutions

Making healthcare more accessible & affordable for patients

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic and Scripps Research are collaborating on rapid-response hantavirus antibody and vaccine development using Dyadic’s proprietary C1 platform for fast, scalable biologic production.
Collaboration builds on prior Andes virus work and funded pandemic preparedness programs involving Gates Foundation, CEPI & ZAPI.
Read the full announcement here:https://t.co/rMcW49Jy1N

$DYAI

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic Applied BioSolutions will be participating in the upcoming Sidoti Virtual Investor Conference on May 20-21.

President & COO Joe Hazelton will present company updates and meet virtually with investors throughout the event.
https://t.co/miDrKxaXr0

#DYAI #Biotech #SyntheticBiology #PrecisionFermentation #Sidoti

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic has signed an OEM distribution agreement with IBT Bioservices to commercialize Dyadic-produced recombinant proteins through IBT’s global research channels.

Initial RUO products are expected to include recombinant DNase I and transferrin—marking an important step toward product-driven revenue.

Read more: https://t.co/65woPb61yt
$DYAI #biotech #lifesciences

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic (NASDAQ: $DYAI) & Fermbox Bio launch animal-origin-free Recombinant DNase I (RNase-free) — the first product under their expanded collaboration.

Research-grade available
cGMP version in development
Targeting CGT & biomanufacturing markets

#Dyadic #DNaseI #Biotech #CellAndGeneTherapy #AnimalFree #PrecisionFermentation
https://t.co/47AjgTHQu9

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic ($DYAI) & Inzymes announce planned 2026 commercialization of recombinant non-animal bovine chymosin following development milestone completion.
Advancing sustainable dairy enzyme solutions via microbial fermentation.

#Biotech #FoodTech #Enzymes #DYAI #Fermentation

Read the full announcement here: https://t.co/SLcnUMZRv1

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic (NASDAQ: DYAI) & Proliant announce the commercial launch of AlbuFree™ DX, a recombinant human albumin produced using Dyadic’s proprietary fungal expression platform.
A key milestone converting licensed programs into recurring revenue streams.
Read more:https://t.co/q8Iplqs61U

#Biotech #RecombinantProtein #CellCulture #AnimalFree #DYAI

[Dyadic Applied BioSolutions @DyadicInc]

Animal-free nutrition at scale

Dyadic and BRIG BIO team up to commercialize recombinant bovine alpha-lactalbumin for infant, medical, and healthy aging nutrition—powered by the Dapibus™ platform.

Full announcement:https://t.co/VAxnbOgGeV

#AltProteins #PrecisionFermentation #FoodTech #NutritionInnovation #DyadicBioSolutions

[Dyadic Applied BioSolutions @DyadicInc]

Q3 2025: Dyadic is executing.
✅New website live
✅First product orders
✅CRISPR license secured
✅Commercial shift underway

Read more:https://t.co/2jp0HIA2Tn
#Q3Results #CRISPR #RecombinantProteins #Biotech #DyadicBioSolutions #InvestorRelations

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic + CRISPR-Cas9

“This agreement gives us the ability to apply CRISPR-Cas9 to develop better strains—faster and with greater precision.”
— Joe Hazelton, President & COO

#CRISPR #ERSGenomics #SyntheticBiology #StrainEngineering #DyadicBioSolutions

https://t.co/0cKmn9XtiY

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic expands into Japan 🇯🇵 and South Korea 🇰🇷
With Intralink, we’re bringing DNase I and Human Transferrin to Asia’s leading biologics and CGT markets.

“We see meaningful opportunities…” — Joe Hazelton

https://t.co/ElPIEhiwLW

#Biologics #CGT #AsiaBiotech #DyadicBioSolutions #RecombinantProteins

[Dyadic Applied BioSolutions @DyadicInc]

RUO to GMP, Dyadic delivers trusted, affordable recombinant proteins
[email protected]
#CellCulture #RecombinantProteins #GMPReady #DNase #MRNA

[Dyadic Applied BioSolutions @DyadicInc]

Why Dyadic for Cell Culture Media?
From recombinant transferrin to growth factors, Dyadic delivers animal-free, scalable, and consistent solutions to power your media formulations.

Designed for flexibility. Engineered for performance.
#CellCulture #RecombinantProteins #MediaOptimization #AnimalFreeBiotech #DyadicBioSolutions #Biomanufacturing #LifeScienceSolutions

[Dyadic Applied BioSolutions @DyadicInc]

Demand is rising. Costs are tight. Traditional protein production can’t keep up. Dyadic’s platform delivers high yields with industrial scalability — a better way to do recombinant production.
https://t.co/wyUPn2cj3q

#RecombinantSolutions #Biotech #ProteinProduction

[Dyadic Applied BioSolutions @DyadicInc]

Biofuels need better enzymes, Dyadic delivers biomass enzyme solutions at global scale.
https://t.co/KTinSKctIE
#Biofuels #Biotech #Cellulosic #Biomass #Ethanol

[Dyadic Applied BioSolutions @DyadicInc]

Tomorrow’s nutrition is animal-free
Dyadic produces recombinant dairy proteins like alpha-lactalbumin for infant & medical nutrition.
🌱 Scalable. Affordable. Sustainable. #Dyadic.com #FoodTech #Nutrition #AltProteins #Animalfreedairy

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic Applied BioSolutions (NASDAQ: DYAI) achieved key Q3 2025 milestones in partnerships with Proliant Health & Biologicals and Inzymes ApS — advancing its transition to a commercially focused biotechnology company.
https://t.co/L2tYwPU63B

[Dyadic Applied BioSolutions @DyadicInc]

Cell Culture and DNA/RNA reagents at scale. Dyadic’s recombinant solutions enable affordable science worldwide.🎥 Watch the Dyadic Advantage in action: "From pharma R&D to products: Dyadic accelerates growth." #DNA #RNA #CellMedia
https://t.co/4PQIE8kJdw

[Dyadic Applied BioSolutions @DyadicInc]

Dyadic Applied BioSolutions delivers affordable, sustainable, reliable solutions
#Animalfree #Recombinanttransferrin #Recombinantalbumin

[Dyadic Applied BioSolutions @DyadicInc]

Engineering Proteins that Power Progress-
#lifesciences #foodandnutrition #bioindustrials

[Dyadic Applied BioSolutions @DyadicInc]

The new Dyadic Applied BioSolutions - #Biotech #DyadicBioSolutions